My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about MELA Download image MELA Sciences. (PRNewsFoto/MELA Sciences, Inc.) IRVINGTON, N.Y., Oct. 2, 2013 /PRNewswire/ -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that developed and is commercializing MelaFind®, the first and only FDA-approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, will participate in the American Society of Dermatologic Surgery (ASDS) Annual Meeting from October 3-6, 2013, at the Hyatt Regency in Chicago, Illinois. (Logo: ...
↧